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Background: World Health Organization (WHO) guidelines recommend early identifica-
tion of patients who have emergency features for early medical intervention with the aim of
reducing child mortality and morbidity. Prognostic models have been developed to be used
in clinical setups, but their performance in external validations has been dismal. These poor
performances have been attributed to suboptimal statistical methods used for derivation of
these scores.
Methods: The Bayesian finite mixture model was used to succinctly identify subpopulations
in a population of 47,596 patients from different geographical regions. Mixed models were
used to derive a final prognostic model taking into account subgroups of the population.
Clinically relevant yet routinely available prognostic factors were used in model develop-
ment.
Results: Amongst the 23 risk factors used, the AVPU scale which measures unconscious-
ness was the strongest predictor of mortality with odds of (AOR=2.94, 95% CI= 2.57 - 3.36).
Oedema (AOR= 2.66, 95% CI= 2.18 - 3.24), pallor (AOR=2.09, 95% CI= 1.86 - 2.36) and the
presence of >= 3 severe comorbidities (AOR=2.19, 95% CI= 1.73 - 2.74) were also associated
with an increased risk of death.
Conclusion: Given that patient are not alike, a statistical methodology that clusters patients
into homogeneous subpopulations should be used to account for the inherent variability in
the medical patients. Computational methodology such as mixture models should be used
to identify inherent subpopulations that underlie the population of medical patients under
study.
Limitation: The use of diagnostic episodes as one of predictors in the model was based on
the clinician’s impression (not a laboratory test) thus the possibility of false positives could
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1.1 Background of the study
Childhood mortality has dropped by a good margin from 11 million in 1990 to 6 million
in 2013 since the implementation of Millennium Development Goal 4 as shown in (Rajarat-
nam et al., 2010). Despite the success, mortality still remains a challenge in Low Income
Countries (LIC henceforth) with statistics showing that nearly half of under-five deaths in
2012 occurred in sub-Saharan Africa as observed by (Alkema et al., 2016). This challenge
seems persistent despite having in place other noble efforts of reducing mortality such as
Integrated Management of Childhood Illness (IMCI) (WHO, 2005).
Paediatric scoring systems have been developed in well-resourced countries and have
been used to describe the severity of illness in paediatric wards. Examples include the Pedi-
atric Early Warning System score (PEWS) derived by (Duncan et al., 2006) which has helped
not only in identifying deteriorating patients in time, but also it has been used in assessing
case-mix differences in different clinical trials. Ideally, prognostic or even diagnostic scores
are not meant to substitute a clinician’s decision in the health facilities, but rather they are
meant to augment their judgment and hence used as job-aids in an emergency setup. This
is particularly important considering that patient-to-clinicians ratio in LIC has been shown
to be high in the paper by (Wakaba et al., 2014).
In LIC, recent studies such as (Ayieko et al., 2015) have shown that hospital mortality
often occurs within the first few hours of admission. Therefore, predicting pediatrics’ out-
come is increasingly becoming important not only in prognosis, but also in planning for
2
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occupancy, staffing and assessment of interventions in the health system research. This has
led to an avalanche of studies aimed at developing clinical prognostic models in order to
rapidly identify patients who are at a higher risk for the purposes of prioritization in admin-
istering treatment in time.
Prediction of paediatrics’s outcome has been of interest as evidenced by a vast majority
of published scores. However, most of the these published scores such as (Pollack et al.,
1988; Shann et al., 1997; Egdell et al., 2008; George et al., 2015; Helbok et al., 2009) are highly
specific to a particular pathogen. Common examples of such pathogens include meningo-
coccal disease and malaria which requires a confirmatory laboratory test. This requirement
of laboratory screening makes their utility limited especially in an emergency setup. Fur-
thermore, laboratory equipments in most of LIC countries are limited as shown by (Ayieko
et al., 2015). Other published scoring systems are faced with numerous challenges such as
paltry sample size and a limited events-per-variable which renders such models to overfit
and hence predict poorly as demonstrated by (Ogundimu et al., 2016; Steyerberg and Ver-
gouwe, 2014).
Typically, the usefulness of a clinical predictive model is measured by its ability to make
correct predictions about future or yet unseen observations. As a result, before any devel-
oped model is put into use, it is a conventional requirement as shown by (Bleeker et al.,
2003) that an independent external validation to be undertaken. The external validation is
often treated preferentially to internal validation of a prediction model. This is because it ad-
dresses generalizability of a derived model rather than reproducibility of the same model as
asserted by (Steyerberg and Vergouwe, 2014). Essentially, a fully external validation study
entails independent researcher(s) studying patients of different geographical location from
the one used during model derivation. Performance of the model is assessed by how well
it discriminates patients with outcome from those without. A good number of developed
paediatric scores have not been generalized because of their poor performance in external
validations. Of note, however, almost all developed prognostic models have blatantly failed
to account for the uncertainty in model selection as recommended by (Hoeting et al., 1999).
Furthermore, they have failed to recognize that there exists sub-populations with different
mortality patterns. Inability to count for such uncertainty leads to a model performing dis-
mally during external validation and thus affecting model transportability.
Page 3
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There is therefore need for a practical prognostic model which is based on hospital rou-
tine measures collected at the bedside that has intuitive range and that does not need a
specific disease or infection to be identified. Such a model would be useful in the real-time
discrimination of patients with high risk of deterioration from those with low risk while




Clinical prognostic models often combine multiple prognostic factors to give an insight into
the relative effects of risk factors in the outcome of interest. Although publications that
present such models are becoming more frequent in the literature, the methodology em-
ployed is often suboptimal. Consequently, poor performance of the derived models is often
observed during their external validations. A model becomes useful if it is able to be gener-
alized and used in the wider population from which the sample is drawn.
In assessing the association between risk factors and patient outcomes, a logistic regres-
sion methodology is often used as a standard method. Under this methodology, a stepwise
regression technique is mostly used to choose a subset of relevant variables despite being
discouraged by (Wynants et al., 2016) and (Ogundimu et al., 2016). Inferences about the
predictors are then made based on the chosen model constructed of only those variables
retained in that model with the assumption of being a unimodal population. However,
in practice multi-modal populations are more common to find than unimodal ones, par-
ticularly in complex phenomena such as pediatric mortality. Therefore, stepwise method
subsequently ignores subpopulations that are inherent in the populations and whose true
data-generating mechanism might be very different from one another.
This limitation may be addressed by adopting a finite mixture model approach, which
is able to utilize researcher’s prior knowledge to come up with finite subpopulations whose
statistical properties are unique to each other. This approach has been shown to account for
uncertainty in the derived model.
Berkley et al. (2003) observed that paediatrics often experience mortality in different
ways; either immediate mortality (on admission), early mortality (few hours after admis-
sion < 48 hours) or late mortality (≥ 48 hours after admission). However, a true hospital
length of stay (LOS) in terms of hours is largely unknown. Hence a true data generating
distribution of pediatric mortality becomes less intuitive because of its multi-modal nature.
These subpopulations has to be identified and accounted for so as to make a predictive
model useful in out-of sample data.
This study, therefore applied mixture model theory, both as a proof of concept and as
an operational model to identify finite subpopulations so as to build an all encompassing
Page 5
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prognostic model. The outcome of interest for this study is all-cause in-hospital mortality.
The principle motivation of using mixture models is that the event of interest(mortality)
being observed cannot be fully modeled by a single, simple model nor characterized simply
by distribution, but rather by multiple of such distributions or models, with some random




This study had the following main objective which is further broken down into specific
objectives:
1.3.1 Main objective
To develop a robust Bayesian-based prognostic model of hospital outcomes for paediatrics
admitted in Kenyan county hospitals.
1.3.2 Specific objectives
1. To identify research gaps and statistical limitations that are in the recently published
prognostic models.
2. To explore the appropriate statistical methodology that can address the limitation iden-
tified in 1 above.
3. To use readily available routine data to develop a generic predictive model using





Clinical prediction models are fundamental in medicine, they have been used to inform
treatment as well as providing information on diagnostic episodes that are possibly present
in a patient given his/her presenting characteristics. Prognostic models make a joint use of
multiple clinical signs of a given disease and other risk prognostic factors to systematically
calculate prognostic indices (probability estimates) that are used to discriminate patients
of high risk from those with low risk as shown in the paper by (Mallett et al., 2010). These
probabilistic discrimination is useful since it augments the clinical intuition of clinicians who
have been shown by (Wakaba et al., 2014) to be in short supply especially in low-income
countries. Of note, however, just a handful of models ends up being used in clinical practice
out of many that are published. But this trend is not without a reason; (Mallett et al., 2010)
and (Mikolajczyk et al., 2008) observed that most of the published prognostic models have
been derived using poor statistical methods that adversely affect their performance during
external validations.
2.2 Heterogeneity in medicine
Researchers using medical data more often than not present results for ’average’ patients
while ignoring potential heterogeneity of patients. This is because most of the standard sta-
tistical models, such as linear regression, estimate the population average effect, which is the
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mean response of all individuals under study. But the population average effect might be a
mixture of some effect, little effect and/or no effect. Thus, using customary statistical meth-
ods considerably fails to appreciate that patients are not alike! Consequently, the resultant
effects of covariates on the quantity of interest tend to mislead! For instance (Schlattmann,
2009) noted that patients react differently to treatment regimes. Observable factors such
as age, gender, etc. could be attributable to such differences. Owing to such heterogeneous
populations, individualization of medical therapies has become necessary. However, the un-
derlying mechanism that triggers patient variability remain unknown. Most of the factors
that are thought to be attributable to patient heterogeneity are largely latent (unobserved)
variables in medical research. For example, information on genetic polymorphisms of pa-
tients remain unknown yet that information is crucial in pharmacokinetic studies. Faced
with unobserved patient heterogeneity, a statistical methodology that handles variability
between individuals due to unobserved covariates has to be used particularly in clinical
predictive models so as to improve performance.
2.3 Methodological flaws in prognosis
In clinical research, multivariate clinical information is integrated to optimally predict pa-
tient status or even disease progression. However, overwhelming evidence arising from a
series of systematic reviews such as (Mallett et al., 2010; Collins et al., 2011, 2014) has pointed
out numerous challenges that make prognostic models perform poorly. They include sam-
ple size, missing data and most importantly inappropriate methodological choice in their
statistical analyses. Models derived from such shortcomings of methodology give overop-
timistic performance during derivation. Therefore, it is not surprising that most of these
suboptimal prognostic models undoubtedly never get to be used as quantified by (Collins
et al., 2016). This is because they can never pass a rigorous test of external validation. Given
that patient are not alike as pointed out in section 2.2, a statistical methodology that clus-
ters patients into homogeneous subpopulations should therefore be used to account for the
inherent variability in the clinical studies.
Page 9
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2.4 Machine Learning(ML) methods
Oermann et al. (2016) defined machine learning as a branch of Artificial Intelligence, which
is an interdisciplinary field combining computer science and mathematical statistics to de-
velop models with maximal predictive accuracy. Kourou et al. (2015) further observed that
ML techniques have the ability to discover, identify patterns and relationships present in
complex datasets. Oermann et al. (2016) applied ML techniques to predict individual pa-
tient outcomes after radiosurgery and reported that the approach provided the best possi-
ble predictions in relation to the methods they were compared with. Based on (Cruz and
Wishart, 2006), the accuracy of cancer prediction outcome has significantly improved by
15%–20% with the application of ML techniques in the prognostic models. Clustering is a
common unsupervised task of ML with the aim of determining intrinsic groupings. That is,
observations with similar characteristics but dissimilar from others are grouped together to
constitute subpopulations. Most of the clustering algorithms are distance-based; they use the
geometric distance matrix as a criterion of grouping observations. The literature has shown
that probability-based clustering is preferred to a distance-based. In particular, (Aitkin et al.,
1981) pointed out that ”when clustering samples from a population, no cluster method is a priori
believable without a statistical model”. The mixture model is an example of such model-based
ML methods used in clustering as we have shown below.
2.4.1 Mixture models
In statistical pattern recognition, the finite mixture model is a probabilistic clustering algo-
rithm used to expose some natural groupings that may underlie the data (heterogeneous
population). Model-based approach to clustering is supported by (Aitkin et al., 1981), who
remarked in their paper that ”clustering methods based on such mixture models allow estimation
and hypothesis testing within the framework of standard statistical theory.”
The main assumption of the mixture model is that each data point yi is a realization of the
mixture density where observations in the model corresponds to clusters/subpopulations.
Probabilistic (soft clustering) of the data into K clusters can be obtained in terms of the fitted
posterior probabilities of component membership for the data as shown by (Schlattmann,
2009). A substantive hard clustering can be subsequently obtained by assigning each obser-
Page 10
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vation to the component to which it has the highest fitted posterior probability of belonging
as demonstrated by (McLachlan and Peel, 1998).
2.4.2 Applications of mixture models in prognosis
• Kusmakar et al. (2016) used Gaussian Mixture Model (GMM) for the identification of
psychogenic non-epileptic seizures. They reported that GMM algorithm accurately
modeled the non-epileptic and epileptic movements, hence enhancing the overall pre-
dictive accuracy of the their model to 91% of the new data.
• Le and Bukkapatnam (2016) utilized a nonparametric statistical Dirichlet-Process to
build a prognostic model in pulse rate dynamics with the aim of predicting real time
onsets of episode before the clinical symptoms appear. They reported that the tech-
nique enhanced effective prediction.
• Lu et al. (2016) used finite mixture model to accurately segment angiography blood
vessels which has played an important role in an interventional treatment of vascular
diseases.
• The mixture model has been used in the identification of high-risk groups in the pro-
cess of disease mapping. Schlattmann et al. (1996) used mixture model approach to
identify spatial heterogeneity in tuberculosis risk and mapped it within an empirical
Bayes framework.
• Gene expression profiling is expected to unveil the underlying molecular features. A
parametric clustering method using the Gaussian mixture model and the Bayes infer-
ence was used by (Muro et al., 2003) and it revealed three groups of expressed genes
in their study.
• Neuroblastoma patients, most of the time, experiences heterogeneous survival out-
comes despite aggressive treatment. Aware of these variabilities, (Hunsberger et al.,
2009) used the finite mixture model to analyze a large cohort of these patients with the
aim of identifying patients with the shared types of neuroblastoma so that individu-
alized interventional therapies could be enhanced. The robustness of these methods





This was a cross-sectional prospective study on patients admitted to paediatric wards across
14 county hospitals in Kenya as shown in Figure 3.1. Selection of these hospitals were pur-
poseful to reflect high and low malaria endemicity both in large rural environments and
urban settings with the condition of a given hospital admitting at least 1,000 children per
year. In general, these hospitals are part of the Clinical Information Network (CIN) which
is a collaboration between researchers from the Kenya Medical Research Institute (KEMRI),
Wellcome Trust Research Programme (WTRP), the Kenya Ministry of Health (MOH), the
Kenya Paediatric Association (KPA) and the University of Nairobi (UON). The main aim
of the CIN was to use de-identified patient level routine data to improve hospital care. A
detailed description of CIN study has been given elsewhere by (Ayieko et al., 2015). All re-
search related activities undertaken by CIN has received approval from the national KEMRI
scientific and ethical review committees.
3.1.1 Data management
Data were abstracted from the patient file by a trained data clerk on the daily basis following
the discharge or death of a patient. The abstracted data were then fed into a customized data
capture tool designed with the non-proprietary Research Electronic Data Capture (REDCap)
platform which has an inbuilt range and validation checks as documented by Harris et al.
(2009). Before the data were synchronized to a central database, the data clerk checked and
12
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Figure 3.1: Location of hospitals under study and their population density
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ensured completeness as well as consistency with locally executed cleaning scripts which
were written in R language. If the error or any inconsistencies were detected in any record, a
data clerk looked for that specific file and verified. Another round of data checks were done
at the central server and in the event of any inconsistencies, data clerks whose record(s) were
problematic were rang to rectify the anomaly. This loops of validation checks guaranteed a
high quality data.
3.1.2 Inclusion criteria
All admissions aged > 1 month hospitalized in the paeditric wards of all 14 CIN partic-
ipating hospitals from September 2013 through December 2016 were deemed eligible for
inclusion to the study. Patients with surgical conditions or burns were excluded because





1. Patients admitted when
 clinicians are on strike,
2. Patients discharged when
 data clerk are on leave,
3. Trauma cases, 






(2 months – 12 years)
Paediatric Admissions to CIN 14 Hospitals 









Bayesian inference is a powerful framework that utilizes Bayes theorem to make inference.
This framework is efficient because all relevant sources of uncertainty and other unknown
quantities are expressed as a random variable.
In this paradigm, current information or knowledge about the parameters of the model
is expressed mathematically by placing a probability distribution on the parameters, termed
as ”prior distribution”, commonly expressed as p(θ).
With the availability of the new data y, the information contained in y pertaining the
model parameters is then expressed as the ”likelihood”. By definition, the likelihood is directly
proportional to the distribution of the observed data given the parameters of the model,
expressed as p(y | θ).
Combination of the likelihood and the prior distribution results to a probability distribution
which is updated. Commonly referred to as ”posterior distribution”. This is where all infer-
ences about the model are based on. Bayes’ Theorem, an elementary identity in probability
theory, states how the updating of posterior distribution is done mathematically as shown
by (Gelman et al., 2014):
p(θ | y) = p(θ)× p(y | θ)∫
Θ p(θ)× p(y | θ) dθ
.
Which is equivalent to,
p(θ|y) ∝ p(θ)× p(y|θ).
3.2.1 Prior specification p(θ)
Priors rules out unreasonable parameter values. As opposed to widely used flat priors, this
study used weakly informative priors to help control inference computationally and statis-
tically. Computationally, (Gelman et al., 2015) showed that a weakly informative prior in-
creases the curvature around the volume where the solution is expected to lie, which in turn
guides MCMC sampler by not allowing them to stray too far from the location of a surface.
Statistically, weakly informative priors are not very sensitive, in the sense that reasonable
changes in the prior do not produce noticeable changes in the posterior.
All models used in this study had different prior specifications based on the complexity
Page 16
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of a given model. Specification of each of the model is as follows;
1. Prior Specification for finite mixture model
Finite Mixture model parameters has three parameters (θ, µ, σ), where θ is the mixture
probabilities, µ is the mixture/components means and σ is the standard deviation of
mixtures as defined by (Gelman et al., 2014).
The weakly informative priors of each is as defined below:
• Dirichlet prior on the mixture proportions p(θ) ∼ Dirichlet(α1, . . . , αH), where
the sum of αh is a measure of the strength of the prior distribution.
The Dirichlet distribution enforces uniqueness of the components in the mixture
model as proven by (Kucukelbir et al., 2015).












2. Prior Specification for mixed effects model.
Mixed model parameters has four parameters (β, µ, σ, α),
where β is the vector of model predictors, µ is the random effect of the mixed model,
σ is the standard deviation of random effect and α is the intercept.
Weakly informative priors of each is as defined below:
• Half Cauchy priors on the model coefficients p(β) ∼ cauchy(0, 2.5).
• Cauchy priors on the model intercept p(α) ∼ cauchy(0, 10).








where K is the number of random effects used in the model.
3.2.2 Sensitivity analysis on priors
Sensitivity analysis entails checks on model settings to assess the robustness of the choice
of priors. Changes in priors, perhaps even slight ones often results in changes in posterior
inferences especially when priors are not robust. We compared our models with plausible
but different priors, different choices did not produce gross changes of inference from the
posterior. We were therefore confident in the final selection of the priors.
3.2.3 Label switching
Definition of label-switching
In order to make inferences with a mixture model we had to learn each of the component
weights θk and the component parameter λk. If the posterior cannot discriminate between
the components, then it cannot discriminate between the component parameters. Put dif-
ferently, individual component distribution is identical with other components πk(y | λk) =
π(y | λk). This phenomena of permuting labels of components/subpopulations in different
chains of MCMC is termed as Label Switching. It arises if the parameters of the mixture com-
ponents have exchangeable priors π(τ(α)) = π(α) then it has been shown by (Gelman et al.,
2014) that the posterior will inherit the permutation invariance of the mixture likelihood as
follows;














λk′ πk′(y | αk′),
= π(α, λ | y).






To avoid the phenomena of label-switching in the mixture model we made exchangeable
prior non-exchangeable by imposing an ordering on parameter space. This technique has
been shown by (Gelman et al., 2014) to be an efficient computational trick which does not
affect the resulting inferences. The solution is defined as follows: given the exchangeable
priors π(α) non-exchangeable prior can be enforced by ordering as shown in equation 3.1
π′(α) =
 π(α), α1 ≤ . . . ≤ αK0, else (3.1)
Further details how ordering of parameters works in a mixture model is demonstrated in
section 3.2.5
3.2.5 Ordering in a Two-component case
The following computations shows how ordering works in a two-mixture components as it
was the case in this study. In the two-component case there are two parameters α1 and α2
and mixture weights θ1 and θ2 = 1− θ1 The desired expectation can be decomposed over
two pyramids that are present in a two-dimensional parameter space as follows;
Eπ[ f ] =
∫
dθ1dθ2dα1dα2 · f (α1, α2) · π(α1, α2, θ1, θ2 | y)
∝
∫








dθ1dθ2dα1dα2 · f (α1, α2) · π(α1, α2)π(θ1, θ2) (θ1π(y | α1) + θ2π(y | α2)).
If we permute parameters as
(α1, α2)→ (β2, β1)
and
(θ1, θ2)→ (λ2, λ1),
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then the second pyramid will be rotated into first as follows;
Eπ[ f ] ∝
∫
α1<α2












dλ1dλ2dβ1dβ2 · f (β2, β1) · π(β2, β1)π(λ2, λ1) (λ1π(y | β1) + λ2π(y | β2)).
Applying permutation-invariance of f and the exchangeability of the priors the second term
will be equivalent to the first term as follows:
Eπ[ f ] ∝
∫
α1<α2
















dθ1dθ2dα1dα2 · f (α1, α2) · π′(α1, α2, θ1, θ2 | y).
Thus, the first and the second terms can be expressed as;
Eπ[ f ] = Eπ′ [ f ]. (3.2)
Equation 3.1 is a simplified form of equation 3.2. Hence it has been shown that taking ex-
pectation over the pyramid defined by the standard ordering yields the same value as the
expectation taken over the entire parameter space.
3.2.6 Computations
All models in this study were implemented in Stan. This is a flexible probabilistic program-
ming framework originally designed by (Gelman et al., 2015) for sampling-based inference.
We had strong reasons for using Stan and they included:
• Stan uses a No-U-Turn (NUT) sampler which is a variant of Hamiltonian Monte Carlo
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(HMC). This sampler technically overcomes a local random-walk behavior which is a
common problem in Gibbs sampler and Metropolis algorithms as excellently shown in
(Betancourt, 2013). These inefficiencies costs a lot of time zigging and zagging while
traversing through the target distribution. As demonstrated by (Gelman et al., 2014),
such random-walk behaviors are very common when BUGS/JUGS is used to estimate
complicated models such as mixture models.
• Stan is coded in C++ which implies that computational time is relatively short as com-
pared to BUGS/JUGS.
• Stan implements Automatc Differentiation Variational Inference (ADVI) which is es-
sential in the computation of machine learning (mixture models) posteriors which are
otherwise computationally intractable because of their closed form. ADVI as docu-
mented by (Kucukelbir et al., 2015) transforms the joint density of any differentiable
probability model to the real coordinate space.
3.2.7 Implementing Bayesian finite mixture model
Let z ∈ {0, . . . , K} be an assignment that indicates to which data generating process a given
sample are generated from. Suppose each of the y = y1, ..., yn items in the sample belong to
one of H subpopulations. For Mathematical convenience, mixture models are often formu-
lated in terms of latent variables indicator zih. Defined as follows
zih =

1 if ith unit is drawn from hth component
0, otherwise
Latent variable indicator are never observed and their values are never known beforehand.
Let h = 1, ..., H, then the hth component distribution is defined as fh(yi | λh) which depends
on parameter vector λh.
Let θh denote the mixing weight of the population from the component h, such that;







the joint likelihood over observations and its subpopulation becomes,
π(y, z | α, θ) = π(y | α, z)π(z | λ) = πz(y | αz) θz.
But, in practice assignment of observation to a subpopulation uses discrete parameters
which are difficult to fit accurately because gradient computations are not tractable. As
a result, inference of such parameters can be done via marginalization of the assignments
which yields a likelihood that depends on only continuous parameters which is essentially
a convex combination of the data generating process as follows:
π(y | α, θ) = ∑
z
π(y, z | α, θ)
= ∑
z










λk πk(y | αk).
The sampling distribution of y then becomes;
p(yi | λ, θ) = θ1 f (yi | λ1) + θ2 f (yi | λ2) + ... + θH f (yi | λH). (3.3)
To incorporate the latent variable indicator zi = (zi1, ..., ziH) is modeled as multinomial with
parameter θ. Mathematically defined as:
z ∼ Multinormial(θ),
where θ = (θ1, ..., θH)T is the vector of probability also known as mixing weights. The
generative process of each observation is then defined as shown below
y | z = h ∼ Gaussian(µk, σk), (3.4)
where h is a component(subpopulation) in the mixture model.
Hence the joint distribution of observed y and a latent indicator z on the model parameter
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can be expressed as follows:







(θh f (yi | λh))zih . (3.5)
3.2.8 Bayesian mixture model posteriors
Bayesian inference over a mixture model requires both mixture likelihood as well as prior
distributions for both the component parameters, λ, and the mixture probabilities, θ. The
posterior distribution for multiple N observations becomes







θH πH(yn | λH), (3.6)
where H is the number of subpopulations, θ is the vector of mixing weights and λ is the




3.3.1 Handling missing data
Before fitting regression models we explored the levels of missingness both in explanatory
and dependent variables. Since the degree of missingness was not ignorable (< 1%), we
conducted multiple imputation under the assumption of Missing At Random (MAR) miss-
ingness mechanism. Using chained equations, we generated 25 dataset with 100 iterations




Opinion from experts (pediatricians) and literature search informed the list of variables that
were deemed to be of clinical relevance in predicting mortality of paediatrics. They in-
cluded:





• Inability to drink/breasfeed
• History of fever









• Number of severe comorbidities
• Time(seconds) to capillary refill
• Pulse(Normal or weak)
• Gender
Variables listed above have been shown to be significant factors of mortality by (Gathara
et al., 2017).
Variable selection
Final prognostic model included all of the above variables which were selected a prior based
on the clinical relevance. As a result, no model building process ensued since these variables
were independent predictors of mortality. Statistical procedures (e.g. stepwise selection)
with a strong focus on significance levels to include or exclude a variable have been highly
discouraged by (Wynants et al., 2016) and (Ogundimu et al., 2016) who observed that models
built from variable selection procedures such stepwise in a binary outcome tends to have a
considerable bias in their coefficients especially in small sample sizes.
Determining the number of subpopulations, K
The first (Model 1) logistic mixed effect model with hospital identity as clustering factors
was fitted with all the listed variables as follows:
Let the linear predictor η be the combination of the fixed effects (Prognostic factors listed
above) and random effects (Hospital identity) excluding the residuals. Our main outcome




η = Xβ + Zγ,
g(·) = link function,
g(·) = loge( p1–p ),
h(·) = g−1(·) = inverse link function,
where the conditional expectation of y is given by g(E(y)) = η,
X is a N × p matrix of the p predictor variables; β is a p× 1 column vector of the fixed-
effects regression coefficients; z is the N × q design matrix for the q random effects; γ is a
q× 1 vector of the random effects; and the linear predictors of the model consist of Xβ.
Using kernel density estimators of the linear predictors, the number of components K
was determined by visually inspecting the plot.
Mixture model specification
Bayesian Mixture Model was specified using an empirical prior distribution for the mean of
the K normal distributions.




θ1N (yn | µ1, σ1) + . . . + θkN (yn | µk, σk),
where K is the number of components which was obtained as explained above.
Mixture model assumption: Mixture model assumes that each observation yi is drawn
from one of the components K independently as opposed to the entire dataset being drawn
from one of the components. Figure 3.3 is the graphical model where θ is the vector of
mixing parameters, µ is the vector of means for the component distributions, α is the prior
mean, and σ represents the prior standard deviation.
3.3.3 Hierarchical modeling
This is a statistical model with either parameters or data structured at different clustering
levels. In most cases, though not necessarily in all cases, data are nested within each other
(Gelman et al., 2014). These models consist both fixed effects and random effect (also known




Figure 3.3: Bayesian graphical model
of subpopulations were used as a random effect.
3.3.4 Procedure of sampling
A set of 4 chains each with 2000 iterations for the mixture model and 1000 iterations for each
of the two mixed models were fitted using Stan. To have a good starting point for Markov
chain Monte Carlo (MCMC) runs, we threw away(burn-in) some iterations at the beginning
of the run for different models as follows; first 200 iterations for mixture model and 100
iterations for each of the two mixed models were discarded as burn-in in each sample. To
reduce autocorrelation in the estimates of the model, a thinning interval of 10 was used.
3.3.5 Assessing diagnostics of MCMC
Convergence of the Bayesian models was assessed by visually inspecting their trace-plots.
Convergence was assumed if the chains intermingled without a definite pattern. Further-
more, we used a scale reduction statistic R̂ (R-hat) as recommended by (Gelman and Rubin,
1992). Ideally, R̂ statistic quantifies the ratio of variance of the draws pooled from all chains
to the average variance of the draws for each chain. Therefore, at equilibrium state all chains
ought to have a R̂ of 1. If any chain has not converged to a common target distribution the
R̂ will be greater than 1.
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3.3.6 Posterior Predictive Distribution (PPD) of the model
To assess whether our model could be used to make predictions for the out-of-sample data,
we used posterior predictive density which is defined as follows. Given observation data y
and a model parameters θ, the posterior predictive distribution for new observation ỹ is
p(ỹ | y) =
∫
Θ
p(ỹ | θ) p(θ | y) dθ,
and the log posterior predictive density defined as;
log p(ỹ | y) = log
∫
Θ
p(ỹ | θ) p(θ | y) dθ.
Thus to validate the fit of our model, we generated new simulated data from the poste-
rior density and calculated the test statistics such as mean, standard deviation, minimum
and maximum which were compared visually with the observed data as recommended by
(Gelman et al., 2014).
3.3.7 Cross validation and model comparison
We used the Watanabe-Akaike information criterion (WAIC) and Leave-one-out cross-validation
(LOO) methods for Bayesian models as recommended by (Gelman et al., 2014) and (Vehtari
et al., 2016) to perform an internal validation of the derived model. To justify the added
complexity in the derived model, we compared its predictive performance against a model
without a random effect of the subpopulation. These methods uses posterior simulations to





4.1.1 Baseline characteristics of derivation cohort
This study included 47,596 participants who met eligibility criteria shown in Figure 3.2.
Proportion of female participants was 44.93% and age in months had a median of 20 (Range
10-46). Mortality varied considerably between hospitals with overall mortality being 2,399
(5.04%) with a range of 0% to 8.8% as shown in Figure 4.1. More than half of the study pop-
ulation (76.1% ) had a history of fever which suggested a possibility of malaria parasitemia



























Figure 4.1: Distribution of mortality in study hospitals
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Median age in Months(IQR) 20 (10 - 46)
Median weight(kgs) (IQR) 10 (7.5 - 14)
Prostration 3881 (8.15)
Grunting 4884 (10.26)
Can’t Drink 7535 (15.83)
History of Fever 36219 (76.1)
History of Diarrhea 14917 (31.34)
Convulsion 10462 (22.1)
AVPU<A 3045 (6.4)
Severe pallor 2895 (6.08)
Central cyanosis 278 (0.58)
Respiratory distress 16115 (33.86)
Impaired Consciousness 4274 (8.98)
Page 31
Chapter 4
4.2 Prognostic model derivation
4.2.1 Detecting existence of subgroups in the larger population
Using Kernel density plots of the linear predictors expressed as
ηi = α + β1AVPUi + β2Central Cynosisi + . . . + βpGenderMalei
of Model 1, two homogeneous subgroups were identified in the study population as shown
in Figure 4.2. Visual inspection of the plot suggested a possibility of two data generating
mechanisms and also the existence of latent variables responsible in distinguishing two sub-


























Figure 4.2: Subpopulations in the study population
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4.2.2 Identifying patients in each of the subpopulation using mixture
models
With the assumption that each observation yi could be drawn from one of 2 data generating
processes as shown in Figure 4.2, we developed a mixture model where we conditioned
on the assignment z ∈ {1, 2} to indicate to which data generating process each of 47,596
observations used in this study were generated.
Convergence of the mixture model was assessed using trace-plots shown in Figure 4.3
and we were convinced that all 4 chains converged to the target distribution. The R̂ was ap-
proximately 1 as shown in Table 4.2 which further suggested a convergence to equilibrium
distribution. The dreaded label switching which is an inherent problem in mixure model was
not of a concern in this case as shown in 4.4. From the results of the estimates of the param-
eters as shown in Table 4.2, the weights of the two mixture components were approximately
θ1 = 0.809 and θ2 = 0.191.
Table 4.2: Mixture model estimates
Parameter Mean standard deviation 95% Credible Interval Rhat
θ1 0.809 0.008 0.793 - 0.825 1.00
θ2 0.191 0.008 0.175 - 0.207 1.00
σ1 0.735 0.005 0.724 - 0.745 1.00
σ2 1.298 0.005 1.267 - 1.331 1.00
µ1 -3.795 0.007 -3.808 - -3.782 1.00
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Figure 4.3: Convergence of mixture model Page 35
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So as to make predictions, probabilistic clustering (soft clustering) were obtained from the
fitted posterior probabilities of component membership. For each 47,596 observations, we
picked one (hard clustering) of the two mixture components which had the highest proba-
bility and its corresponding probability. The distribution of each of probability for each of
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Two data generating processes
Figure 4.5: Data generating processes
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4.2.3 Prognostic model results
All 4 chains used in estimating the prognostic logistic model converged to the target dis-
tribution in all of the predictors we were considering as shown in Figure 4.6. As a result,
we proceeded to make inference. Odds ratios (ORs) and 95 per cent confidence intervals
(CIs) are included to enhance interpretability. The AVPU scale which measures unconscious-
ness was the strongest predictor of mortality with odds of (AOR=2.94, 95% CI= 2.57 - 3.36).
Oedema (AOR= 2.66, 95% CI= 2.18 - 3.24) , pallor (AOR=2.09, 95% CI= 1.86 - 2.36) and the
presence of >= 3 severe comorbidities (AOR=2.19, 95% CI= 1.73 - 2.74) were also associated
with an increased risk of death as shown in Table 4.3 and in Figure 4.7. Indrawing was the
single most respiratory distress that the strongest predictor of mortality.
Table 4.3: Prognostic model estimates
Predictor Adjusted Coefficient(Odds ratio) 95% Credible Interval
AVPU Not Alert 2.94 2.57 - 3.36
central cyanosis 1.88 1.32 - 2.67
Grunting 0.84 0.71 - 0.99
Acidiotic breath 1.70 1.42 - 2.05
Severe pallor 0.84 0.71 - 0.99
Acidiotic breath 1.70 1.42 - 2.05
Cannot drink 1.89 1.7 - 2.11
History of fever 0.82 0.74 - 0.91
History of diarrhoea 1.44 1.3 - 1.59
Indrawing 2.04 1.83 - 2.28
Pallor 2.09 1.86 - 2.36
StiffNeck 1.97 1.6 - 2.42
skin pinch 1-2 seconds 1.23 1.09 - 1.38
Skin pinch >= 2 seconds 1.91 1.62 - 2.23
Jaundice 1.28 0.99 - 1.62
Oedema 2.66 2.18 - 3.24
1 comorbidity 1.10 0.9 - 1.33
2 comorbidity 1.75 1.43 - 2.15
>= 3 comorbidity 2.19 1.73 - 2.74
capillary refill 2 seconds 1.04 0.93 - 1.16
capillary refill Indeterminate 0.84 0.62 - 1.11
capillary refill > 2seconds 1.31 1.12 - 1.53
Weak Pulse 1.74 1.51 - 2.00
Male 0.80 0.73 - 0.88
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cap_refill_cat>2 sec pulseweak child_sexMale
comobidities1 comobidities2 comobidities>=3 cap_refill_cat2 Sec cap_refill_catIndeterminate
stiffNeck.yesTRUE skin_pinch1 −2 secs skin_pinchmore than or equal to 2secs jaundice.yesTRUE oedema.yesTRUE
cant.drinkTRUE histrory.feverTRUE histrory.diarrhoeaTRUE indrawing.yesTRUE pallor.yesTRUE
avpuNotAlertTRUE central.cyanosisTRUE has.gruntingTRUE has.severe.pallorTRUE has.acidiotic.breathTRUE
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Posterior distributions
Figure 4.7: Posterior distribution of the model predictors
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4.3 Posterior predictive density
4.3.1 Distributions of test statistics
Following the recommendation by (Gelman et al., 2014) for assessing the posterior predictive
distribution for the test statistic such as mean and standard deviation, we simulated data
from the posterior distribution and compared the distribution of mean in the generated
simulation with the mean in the observed outcome as shown in Figure 4.8. The value of test
statistic T which is computed from the observed data is shown as a vertical dark line T(y).
The plot also shows the vast majority of the simulated data sets under the model having
mean and standard deviation which approximately equal to the observed data. Hence we
concluded that our model made realistic predictions.
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5.1.1 Principal findings in relation to the literature
Using a robust Bayesian approach we derived a new prognostic risk tool to be used in Kenya
as well as other low-in-come countries(LIC). Bayesian approach allowed us to make more
accurate predictions with the data that was available. To the best of our knowledge, this
is the largest such study that utilizes routine data from multiple hospitals over a span of 3
years to have ever been undertaken in a predefined paediatrics population in LIC. Using the
posterior predictive distribution of the derived model, we simulated data and comparative
key statistics such as mean, standard deviation, minimum, a maximum predicted values as
recommended by (Gelman et al., 2014). Results are as shown in Figure 4.8 which made us
conclude that the derived model has a better calibration in out-of sample data. Furthermore,
we compared the empirical distribution of the observed data to the distributions of simu-
lated data from the posterior predictive distribution. The smoothed kernel density estimate
seemed identical as shown in Figure 5.1 an indicator of a well calibrated model. However,
since this validation was done on the simulated data of the derived model, we are aware that
it potentially has some limitation. Consequently, an external validation has to be performed
to assess transportability of this model before it is deployed in clinical practice.
The final model was to some extent complex given that it included more variables than
recently derived models such as (George et al., 2015) and (Berkley et al., 2003). But this com-
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plexity was necessary considering the fact that the chosen variables are routinely collected
at the bedside which do not require laboratory confirmation. Furthermore, the number of
variables used was justified with the number of events in the current study hence events-
per-variable rule as described by (Ogundimu et al., 2016) was not violated. Furthermore, no
statistical procedures were used such as step-wise methods as applied in the cited studies to
arrive at the final variables, rather the selection was based on the knowledge of the experts
in paediatrics. This approach has been endorsed by (Wynants et al., 2016) and (Ogundimu
et al., 2016) who have discouraged the automatic selection of features based on statistical
significance.
For the derived models to be useful in the out-of-sample data, the derivation dataset
has to be of better quality both in dependent variable and the prognostic factors. Although
variables such as vital signs (respiratory rate, pulse rate) were amongst the listed predictors of
mortality, we chose not to include them in the final model because we suspected a presence
of digit-preference by the observer; theses indicators are manually counted and sometimes
approximated to a nearest number as shown in the Appendix 1. Thus their quality is not
guaranteed. Exclusion of these variables, therefore meant that our estimates will not be
limited to only patients where these vital signs are manually counted.
Current prognostic models tend to over-predict or under-predict during external valida-
tions. Most of them are not well calibrated for the paediatric population and they make a
huge assumption that patients are alike! An assumption which is not entirely correct. As
demonstrated in this study, there exists subgroups that underlie the population under study.
These subgroups arise as a result of latent variables or some other random mechanisms at
play, which the traditional statistical methods fail to take into account hence the utility of
mixture model in this current study to identify observations that consists of subgroups as
shown in Figure 4.2. We have demonstrated that a model that included subgroups had
the better predictive ability than a model without. To achieve that we used leave-one-out
cross-validation methods for Bayesian models as described by (Vehtari et al., 2016).
The derived model included hospital identity as one of the random effect. This deci-
sion improved the fit and was justified by the fact that hospitals under study were located
in different geographical locations as shown in Figure 3.1 which serve different popula-
tions(rural/urban), different malaria endemicity(high/low) and also have different mortal-
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ity rates as shown in Figure 4.1.
Crepitations or indrawing as is commonly referred to was the single most respiratory
distress that the strongest predictor of mortality. These findings support the WHO recom-
mendation of using danger signs at admission as a proxy indicator of probable pneumonia
diagnosis. This observation coincides with the findings by (George et al., 2015).
5.1.2 Future work
Laboratory test results were not considered as one of the potential prognostic factors. This
is because laboratory results might not be easily available at admission especially for emer-
gence cases. Consequently, we consider this as a leeway for the future studies to include
laboratory tests as prognostic factors for the inpatient population. Furthermore, time-to-
event analysis should be considered as an extension of this work to come up with hazards
of deaths using prognostic factors identified in this study.
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5.1.3 Strengths and limitations
One crucial limitation is that, despite vitals signs (temperature, respiratory rate, pulse rate) be-
ing shown as a potential prognostic factor in studies elsewhere, such as (George et al., 2015),
this current study was persuaded to drop them from the list of useful risk factors based
on the strongest evidence of digit heaping. Another limitation was the use of diagnostic
episodes as one of our predictors, these episodes were solely based on the clinician’s im-
pression (not a laboratory test) so the possibility of false positives could not be ruled out.
One of the main strengths is that, this study was based on a large and a representative
pediatric population with data collected over time from different hospitals. Data abstraction
from a patient file had a series of rigorous data validation checks as detailed by (Ayieko et al.,
2015). This means that the data used in this study was of high quality. The use of multiple
imputation increased the power of this study since we were able to utilize all available data





Standard customary statistical methods have been successful to a larger extent in explana-
tory analysis. But the same is not true when applied in developing predictive models, partic-
ularly when using larger complex medical datasets. Given that patient are not alike, a statis-
tical methodology that clusters patients into homogeneous subpopulations should be used
to account for the inherent variability in the medical patients. Computational methodology
such as mixture models should be used to identify inherent subpopulations that underlie
the population of medical patients under study. Once each observation has been linked to
its corresponding subpopulation, a mixed effect prognostic model can be built where sub-
populations will serve as a random-effect (clustering variable). The resulting coefficients
will approximate a true data generating model.
Despite this current study being based on simple routine clinical signs, it has shown
a promise of better predictive ability. Thus, our results need to be externally validated to
assess the transportability of the model, particularly in a non-malaria regions because we
suspected the presence of malaria parasitemia in a larger proportion of derivation dataset.
We believe that this prognostic model could be invaluable in assessing the clinical care.
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int<lower=1> N; // total number of observations
int Y[N]; // response variable
int<lower=1> K; // number of population-level effects
matrix[N, K] X; // population-level design matrix









vector[K] b; // population-level effects
vector<lower=0>[M_1] sd_1; // group-level standard deviations








r_1_1 = sd_1[1] * (z_1[1]);
eta = X * b ;
for (n in 1:N) {





for( k in 2:K){
b[k]~ cauchy(0, 2.5); //Gelman 2008 (Coefficients)
}
b[1] ~ cauchy(0, 10); //Gelman 2008 (Intercept)
sd_1 ~ student_t(3, 0, 10);











int<lower=1> k_groups; // number of mixture components
int<lower=1> N; // number of data points






simplex[k_groups] theta; // mixing weights
ordered[k_groups] mu; //ordered for identifiability
real<lower=0> sigma[k_groups]; // scales of mixture components
}
model {
//Contribution from each component
real contributions[k_groups]; // temp for log component densities
//priors
sigma ~ cauchy(0, 2.5);
mu ~ normal(0, 10);
theta ~ dirichlet(rep_vector(5,k_groups));
//likelihood
for (n in 1:N) {
for (k in 1:k_groups) {





//Abstraction of probabilities of each observation belonging to a given mixture component
generated quantities {
matrix[N, k_groups] p;
for (n in 1:N){
vector[k_groups] ps;
for (K in 1:k_groups){













int<lower=1> N; // total number of observations
int Y[N]; // response variable
int<lower=1> K; // number of population-level effects
matrix[N, K] X; // population-level design matrix














matrix[N, K - 1] Xc; // centered version of X
vector[K - 1] means_X; // column means of X before centering
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Kc = K - 1; // the intercept is removed from the design matrix
for (i in 2:K) {
means_X[i - 1] = mean(X[, i]);




vector[Kc] b; // population-level effects
real temp_Intercept; // temporary intercept
vector<lower=0>[M_1] sd_1; // group-level standard deviations
vector[N_1] z_1[M_1]; // unscaled group-level effects
vector<lower=0>[M_2] sd_2; // group-level standard deviations







r_1_1 = sd_1[1] * (z_1[1]);




mu = Xc * b + temp_Intercept;
for (n in 1:N) {
mu[n] = mu[n] + (r_1_1[J_1[n]]) * Z_1_1[n] + (r_2_1[J_2[n]]) * Z_2_1[n];
}
// prior specifications
sd_1 ~ student_t(3, 0, 10);
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z_1[1] ~ normal(0, 1);
sd_2 ~ student_t(3, 0, 10);







real b_Intercept; // population-level intercept





End-Digit preference of the vital signs readings at admission
 
Figure 1: End-Digit preference of the vital signs readings at admission
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